Patent 10946066 was granted and assigned to Cornell University Press on March, 2021 by the United States Patent and Trademark Office.
A method of enhancing or initiating regeneration of an organ in a subject in need thereof comprising the administration of endothelial cells specific to said organ, or inductive endothelial cells specific to said organ, into the area of the body in which organ regeneration is desired in said subject.